EUVIMEDEUVIMED entdecken
Crossref

Low-dose Lipopolysaccharide Alleviates Spinal Cord Injury-induced Neuronal Inflammation by Inhibiting microRNA-429-mediated Suppression of PI3K/AKT/Nrf2 Signaling

Weichao Li, Tao Tang, Shaoping Yao, Shixiao Zhong, Qianbo Fan, Tiannan Zou

Molecular Neurobiology · 2024

DOI: 10.1007/s12035-023-03483-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Neurobiology, 2024. Verfasst von Weichao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The First People's Hospital of Yunnan province, Affiliated Hospital of Kunming University of Science and Technology…. Hauptthemen laut MEDLINE: MicroRNAs, Spinal Cord Injuries. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: the National Natural Science Foundation of China (Grant No.: 82260257), Key Research Project of Yunnan Provincial Science and Technology (Grant No.: 202102AA310042; 202001AS070028), Yunnan Health Training Project of High Level Talents (Grant No.: H-2018100).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the impact of low-dose lipopolysaccharide (LPS) on spinal cord injury (SCI) and the potential molecular mechanism. Rats were randomly assigned to four groups: Sham, SCI, SCI + LPS, and SCI + LPS + agomir. Allen's weight-drop method was used to establish an in vivo SCI model. The Basso Bcattie Bresnahan rating scale was employed to monitor locomotor function. An in vitro SCI model was constructed by subjecting PC12 cells to oxygen and glucose deprivation/ reoxygenation (OGD/R). Enzyme-linked immunosorbent assay (ELISA) was applied for the determination interleukin (IL)-1β and IL-6. The dual luciferase reporter assay was used to validate the targeting of microRNA (miR)-429 with PI3K. Immunohistochemical staining was used to assess the expression of PI3K, phosphorylated AKT and Nrf2 proteins. The Nrf2-downstream anti-oxidative stress proteins, OH-1 and NQO1, were detected by western blot assay. MiR-429 expression was detected by fluorescence in situ hybridization and real-time quantitative reverse transcription PCR. In vitro, low-dose LPS decreased miR-429 expression, activated PI3K/AKT/Nrf2, inhibited oxidative stress and inflammation, and attenuated SCI. MiR-429 was found to target and negatively regulate PI3K. Inhibition of miR-429 suppressed low-dose LPS-mediated oxidative stress and inflammation via activation of the PI3K/AKT/Nrf2 pathway. In vivo, miR-429 was detectable in neurons. Inhibition of miR-429 blocked low-dose LPS-mediated oxidative stress and inflammation via activation of the PI3K/AKT/Nrf2 pathway. Overall, low-dose LPS was found to alleviate SCI-induced neuronal oxidative stress and inflammatory response by down-regulating miR-429 to activate the PI3K/AKT/Nrf2 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsSpinal Cord InjuriesAnimalsRatsApoptosisIn Situ Hybridization, FluorescenceInflammationLipopolysaccharidesNeuronsNF-E2-Related Factor 2Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRats, Sprague-Dawley

Stichwörter der Autor:innen

InflammationLow-dose lipopolysaccharideOxidative stressPI3K/AKT/Nrf2microRNA-429

Substanzen

LipopolysaccharidesMicroRNAsNF-E2-Related Factor 2Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktMIRN429 microRNA, rat

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, The First People's Hospital of Yunnan province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
  • Faculty of Medical Science, Kunming University of Science and Technology, Kunming, 650500, China.
  • Yunnan Key Laboratory of Digital Orthopaedics, Kunming, 650032, China.
  • Department of Orthopedic Surgery, The First People's Hospital of Yunnan province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China. Z18468184465@163.com.
  • Yunnan Key Laboratory of Digital Orthopaedics, Kunming, 650032, China. Z18468184465@163.com.

Förderung

  • the National Natural Science Foundation of China (Grant No.: 82260257)
  • Key Research Project of Yunnan Provincial Science and Technology (Grant No.: 202102AA310042; 202001AS070028)
  • Yunnan Health Training Project of High Level Talents (Grant No.: H-2018100)
  • Key project of Yunnan clinical medicine research center (Grant No.: 2022YJZX-GK02)
  • Training and Development Project of Yunnan clinical medicine center (Grant No.: 2021LCZXXF-CS02)

Zitieren

APA

Li, W., Tang, T., Yao, S., Zhong, S., Fan, Q., & Zou, T. (2024). Low-dose Lipopolysaccharide Alleviates Spinal Cord Injury-induced Neuronal Inflammation by Inhibiting microRNA-429-mediated Suppression of PI3K/AKT/Nrf2 Signaling. Molecular Neurobiology. https://doi.org/10.1007/s12035-023-03483-9

Vancouver

Li W, Tang T, Yao S, Zhong S, Fan Q, Zou T. Low-dose Lipopolysaccharide Alleviates Spinal Cord Injury-induced Neuronal Inflammation by Inhibiting microRNA-429-mediated Suppression of PI3K/AKT/Nrf2 Signaling. Molecular Neurobiology. 2024. doi:10.1007/s12035-023-03483-9

BibTeX
@article{Li2024,
  author = {Li, Weichao and Tang, Tao and Yao, Shaoping and Zhong, Shixiao and Fan, Qianbo and Zou, Tiannan},
  title = {Low-dose Lipopolysaccharide Alleviates Spinal Cord Injury-induced Neuronal Inflammation by Inhibiting microRNA-429-mediated Suppression of PI3K/AKT/Nrf2 Signaling},
  journal = {Molecular Neurobiology},
  year = {2024},
  doi = {10.1007/s12035-023-03483-9}
}
Kostenlos starten →